Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01434342 · ClinicalTrials.gov registry record · Early Phase 1
Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients
A Early Phase 1 study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 146
- Enrollment target
NCT01434342 is a Early Phase 1 study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 146 participants.
The verdict
NCT01434342, a Early Phase 1 study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 146 participants
- Enrollment target
Study Summary
RATIONALE: Continued smoking after a cancer diagnosis has important health consequences beyond the risks associated with smoking in the general population. Smoking reduces the efficacy of cancer treatments including surgery, radiation and chemotherapy. Despite the negative consequences, it is estimated that between 15-75% of patients with cancer continue to smoke after their cancer diagnosis. Lung, breast, prostate, colorectal, bladder, head \& neck, and cervical cancer patients were chosen because there is evidence of potential clinical benefit associated with quitting smoking in all of these populations and they represent a mix of both smoking and non-smoking related cancers.
Interventions
- DRUG Nicotine Replacement Patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2011-10-01 |
| Est. Completion | 2015-01-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01434342
The ClinicalTrials.gov registry entry for NCT01434342 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 146 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nicotine Replacement Patch is the first listed.
NCT01434342 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01434342 about?
NCT01434342 is a clinical study titled "Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients". RATIONALE: Continued smoking after a cancer diagnosis has important health consequences beyond the risks associated with smoking in the general population. Smoking reduces the efficacy of cancer treatments including surgery, radiation and chemotherapy. Despite the negative consequences, it is estima...
What is the current status of trial NCT01434342?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 146 participants. The study started on 2011-10-01. Estimated completion is 2015-01-01.
What interventions are being tested in trial NCT01434342?
The interventions under investigation include: Nicotine Replacement Patch (DRUG).
Who is sponsoring clinical trial NCT01434342?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.